18 results
DEF 14A
APGE
Apogee Therapeutics, Inc.
24 Apr 24
Definitive proxy
4:15pm
and our historical compensation practices. In the case of new hire executive officers, their compensation is primarily determined based
10-K
2023 FY
APGE
Apogee Therapeutics, Inc.
5 Mar 24
Annual report
6:15am
or in collaboration with others;
generate revenue from commercial sales of programs for which we receive marketing approval;
hire additional personnel including … strategic alliances or sublicense our rights to collaborators, engage with scientific advisors or hire employees or consultants, each of which would have
DRS
APGE
Apogee Therapeutics, Inc.
9 Feb 24
Draft registration statement
12:00am
receive marketing approval;
hire additional personnel including research and development, clinical and commercial personnel;
add operational, financial … strategic alliances or sublicense our rights to collaborators, engage with scientific advisors or hire employees or consultants, each of which would have
10-Q
r3z15fz
28 Aug 23
Quarterly report
8:00am
10-Q
EX-10.2
zpfuxayapny39ccndg
28 Aug 23
Quarterly report
8:00am
10-Q
EX-10.3
uptq fgkcw76jiugjk44
28 Aug 23
Quarterly report
8:00am
10-Q
EX-10.4
yu9bpf
28 Aug 23
Quarterly report
8:00am
424B4
5gc31r ohbw0l0j004
17 Jul 23
Prospectus supplement with pricing info
4:08pm
S-1
svjtcf
22 Jun 23
IPO registration
4:19pm
S-1
EX-3.1
7dsb2
22 Jun 23
IPO registration
4:19pm
DRS/A
uwxczjhz
5 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
EX-3.1
05950wx5n91go0 hraqo
5 Jun 23
Draft registration statement (amended)
12:00am
DRS
EX-3.1
kf87oq ff77wfw9d2mms
28 Apr 23
Draft registration statement
12:00am
DRS
1kszbcqiv f9sij
28 Apr 23
Draft registration statement
12:00am
- Prev
- 1
- Next